Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...

Drug Dosing: Obese Patients

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...

Vitamins

Vitamins

Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced in our...

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Use of tryptophan-fortified hydrolyzed collagen for nutritional support.

Journal of dietary supplements·2012

Same author

Multivitamin Supplementation During Pregnancy: Emphasis on Folic Acid and l-Methylfolate.

Reviews in obstetrics & gynecology·2012

Same author

Folic Acid supplementation and pregnancy: more than just neural tube defect prevention.

Reviews in obstetrics & gynecology·2011

Same author

A review of dietary fiber and health: focus on raisins.

Journal of medicinal food·2011

Same author

Omega-3 Fatty acids and pregnancy.

Reviews in obstetrics & gynecology·2011

Same author

Omega-3 Fatty Acid supplementation during pregnancy.

Reviews in obstetrics & gynecology·2009

Search research articles

Related Experiment Video

Updated: May 23, 2026

Multidisciplinary Approach to Obesity Management: A Case Report

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Do dietary supplements help promote weight loss?

Stacey J Bell¹, Wendy Van Ausdal, Greg Grochoski

¹IdeaSphere Inc, Belmont, MA 02478, USA. staceyjbell@yahoo.com

Journal of Dietary Supplements

|March 23, 2012

Summary

Effective weight loss supplements are crucial for the overweight population. This review identifies specific dietary ingredients and blends that promote safe and effective weight loss, some surpassing over-the-counter options.

More Related Videos

Rapid Model to Evaluate the Anti-Obesity Potential of a Combination of Syzygium aromaticum (Clove) and Cuminun cyminum (Cumin) on C57BL6/j Mice Fed High-Fat Diet

Rapid Model to Evaluate the Anti-Obesity Potential of a Combination of Syzygium aromaticum (Clove) and Cuminun cyminum (Cumin) on C57BL6/j Mice Fed High-Fat Diet

Published on: July 31, 2021

Related Experiment Videos

Last Updated: May 23, 2026

Multidisciplinary Approach to Obesity Management: A Case Report

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Rapid Model to Evaluate the Anti-Obesity Potential of a Combination of Syzygium aromaticum (Clove) and Cuminun cyminum (Cumin) on C57BL6/j Mice Fed High-Fat Diet

Rapid Model to Evaluate the Anti-Obesity Potential of a Combination of Syzygium aromaticum (Clove) and Cuminun cyminum (Cumin) on C57BL6/j Mice Fed High-Fat Diet

Published on: July 31, 2021

Area of Science:

Nutrition Science
Dietary Supplements
Weight Management

Background:

Two-thirds of the US population is overweight or obese, necessitating new weight loss strategies.
Dietary supplements are a popular weight loss option, but clinical evidence for efficacy is often lacking.
Identifying effective supplements is crucial for public health.

Purpose of the Study:

To identify and evaluate published clinical studies on the effectiveness of dietary supplements for weight loss.
To determine which specific ingredients and blends demonstrate efficacy in promoting weight loss.
To compare the effectiveness of identified supplements against over-the-counter (OTC) orlistat.

Main Methods:

Systematic literature search for published clinical studies on dietary supplements for weight loss.
Defined effectiveness as promoting 1-2 lbs of weight loss per week.
Compared weight loss results of supplements to OTC orlistat.

Main Results:

Only 14 published studies were identified among numerous marketed supplements.
Four individual ingredients and three blends were found to be effective for weight loss.
Five single ingredients and three blends showed greater weight loss than OTC orlistat.

Conclusions:

A limited number of dietary supplements have demonstrated clinical efficacy for weight loss.
Healthcare providers and consumers should prioritize supplements with proven effectiveness.
Further research may be needed to expand the options for evidence-based weight management supplements.